marijuana stocks news

Will Insys Therapeutics (INSY) Continue to Surge Higher? – Tale of the Tape

As of late, it has definitely been a great time to be an investor in Insys Therapeutics Inc (INSY). The stock has moved higher by 17.3% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider INSY’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as INSY has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.

 

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cresco Labs Inc. (CRLBF) to Report Third Quarter 2024 Financial Results on November 8, 2024

Cresco Labs to Report Third Quarter 2024 Financial Results on November 8,…

ADVANTIS CORPORATION (ADVT) Moves Forward with Plans to Establish Los Angeles Presence

Advantis Corp. Moves Forward with Plans to Establish Los Angeles Presence, Partners…

Greenlane Holdings, Inc. (GNLN) Announces $5.4 Million Registered Direct Offering

Greenlane Holdings, Inc. Announces $5.4 Million Registered Direct Offering Greenlane Holdings, Inc.…

GT Biopharma Inc. (GTBP) Begins Manufacturing of “Non-Opioid” Pain-Brake Drug

GT Biopharma Begins Manufacturing of “Non-Opioid” Pain-Brake Drug to Compete in Multi-Billion…